Can Prostate Cancer Prognosis Be Predicted With Accuracy?
Prostate cancer prognosis means forecasting about the onset of Prostate tumor.
This includes assessing the stage at which it is entrenched in the body and the various researches by multiple systems like allopathic, alternate medicines etc.
The main solace about the disease is that it is very rarely lethal.
In a study coauthored by Peter Albertson of the University of Connecticut Health Center in Farmington, it is stated: "Because it usually grows slowly, many tiny cancers probably do not need treatment.
These are the men who should consider active surveillance".
Since 1990, the prostate cancer prognosis has registered a very significant improvement when Australian researchers have diagnosed a close relationship between cancer's occurrence and the consumption of relatively high fat, processed/grilled meats.
It was also established that those who regularly consume vegetables like broccoli, cauliflower, cabbage, and sprouts were less susceptible to the risk of prostate tumor development.
Men in developed countries like Europe and especially USA are very susceptible to the incidence of prostate tumor compared to e.
g.
South Asia, primarily due to the lifestyle and rich foods.
In the case of men in USA, the chances of getting a prostate tumor during one's lifetime is about 16%, so taking a yearly test for prostate cancer is highly recommended.
The glad news is that as per a 2006 study in the Journal of the American Medical Association, men who have low-grade prostate tumors have a minimal risk of dying from them up to 20 years after prostate cancer prognosis.
In general, elderly men above 50 are prone to this disease.
So it is better to know about the symptoms: passing urine with difficulty, complete inability to urinate, passing urine often especially at night, weak or sporadic urine flow, pain while in urinating, blood in the urine and pain the lower back, hips and thighs.
Men with such symptoms should take a test for prostate cancer, as these symptoms are common for non-cancerous benign prostate enlargement also.
Some families exhibit a higher risk incidence for prostate cancer.
The normal risk factor is 1 in 13.
But if in the family the father or brothers had prostate tumor sometime before the age of 70, the chances of getting it by the individual rises to between 1 in 4 to 1 in 7.
So, those with the family history of tumors should start taking a yearly test for prostate cancer at the age of forty.
Digital rectal exams (DRE) and blood tests for prostate-specific antigen (PSA) are routinely conducted.
Prostate cancer prognosis depends entirely on the advancements in the field of tests for the same.
This includes assessing the stage at which it is entrenched in the body and the various researches by multiple systems like allopathic, alternate medicines etc.
The main solace about the disease is that it is very rarely lethal.
In a study coauthored by Peter Albertson of the University of Connecticut Health Center in Farmington, it is stated: "Because it usually grows slowly, many tiny cancers probably do not need treatment.
These are the men who should consider active surveillance".
Since 1990, the prostate cancer prognosis has registered a very significant improvement when Australian researchers have diagnosed a close relationship between cancer's occurrence and the consumption of relatively high fat, processed/grilled meats.
It was also established that those who regularly consume vegetables like broccoli, cauliflower, cabbage, and sprouts were less susceptible to the risk of prostate tumor development.
Men in developed countries like Europe and especially USA are very susceptible to the incidence of prostate tumor compared to e.
g.
South Asia, primarily due to the lifestyle and rich foods.
In the case of men in USA, the chances of getting a prostate tumor during one's lifetime is about 16%, so taking a yearly test for prostate cancer is highly recommended.
The glad news is that as per a 2006 study in the Journal of the American Medical Association, men who have low-grade prostate tumors have a minimal risk of dying from them up to 20 years after prostate cancer prognosis.
In general, elderly men above 50 are prone to this disease.
So it is better to know about the symptoms: passing urine with difficulty, complete inability to urinate, passing urine often especially at night, weak or sporadic urine flow, pain while in urinating, blood in the urine and pain the lower back, hips and thighs.
Men with such symptoms should take a test for prostate cancer, as these symptoms are common for non-cancerous benign prostate enlargement also.
Some families exhibit a higher risk incidence for prostate cancer.
The normal risk factor is 1 in 13.
But if in the family the father or brothers had prostate tumor sometime before the age of 70, the chances of getting it by the individual rises to between 1 in 4 to 1 in 7.
So, those with the family history of tumors should start taking a yearly test for prostate cancer at the age of forty.
Digital rectal exams (DRE) and blood tests for prostate-specific antigen (PSA) are routinely conducted.
Prostate cancer prognosis depends entirely on the advancements in the field of tests for the same.
Source...